Accessibility Menu
 
BioNTech Se logo

BioNTech Se

(NASDAQ) BNTX

Current Price$89.36
Market Cap$22.44B
Since IPO (2019)+533%
5 Year-16%
1 Year-7%
1 Month-17%

BioNTech Se Financials at a Glance

Market Cap

$22.44B

Revenue (TTM)

$2.86B

Net Income (TTM)

$1.13B

EPS (TTM)

$-5.23

P/E Ratio

-17.07

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$89.36

Volume

36,545

Open

$88.78

Previous Close

$89.36

Daily Range

$87.26 - $89.66

52-Week Range

$79.52 - $124.00

BNTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioNTech Se

Industry

Biotechnology

Employees

7,807

CEO

Ugur Sahin, MD

Headquarters

Mainz, 55131, DE

BNTX Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

-46%

Net Income Margin

-40%

Return on Equity

-6%

Return on Capital

-7%

Return on Assets

-5%

Earnings Yield

-5.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$22.44B

Shares Outstanding

251.32M

Volume

36.55K

Short Interest

0.00%

Avg. Volume

1.21M

Financials (TTM)

Gross Profit

$2.14B

Operating Income

$623.87M

EBITDA

$256.17M

Operating Cash Flow

$438.00M

Capital Expenditure

$168.19M

Free Cash Flow

$269.81M

Cash & ST Invst.

$14.83B

Total Debt

$267.29M

BioNTech Se Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$898.89M

-24.5%

Gross Profit

$568.72M

-39.9%

Gross Margin

63.27%

N/A

Market Cap

$22.44B

N/A

Market Cap/Employee

$3.31M

N/A

Employees

6,772

N/A

Net Income

$302.14M

-216.4%

EBITDA

$67.36M

-114.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$14.57B

-11.9%

Accounts Receivable

$984.48M

-35.4%

Inventory

$110.65M

-60.9%

Long Term Debt

$215.11M

+0.2%

Short Term Debt

$52.18M

+32.1%

Return on Assets

-5.15%

N/A

Return on Invested Capital

-6.62%

N/A

Free Cash Flow

$237.67M

+139.5%

Operating Cash Flow

$299.18M

+159.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UTHRUnited Therapeutics Corporation
$524.28-0.52%
STESTERIS plc
$220.03+0.97%
PHGKoninklijke Philips N.V.
$26.25-2.27%
RPRXRoyalty Pharma plc
$45.36-0.37%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About BNTX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.